Compare Electronic Arts Inc. (EA) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Electronic Arts Inc. vs Zimmer Biomet Holdings Inc — how do they compare? Electronic Arts Inc. trades at $207.31 (market cap $51.97B), while Zimmer Biomet Holdings Inc trades at $92.54 (market cap $17.44B). The key difference: Electronic Arts Inc. is far larger — about 3× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays the higher dividend (1.07%). Which is the better fit depends on your goals.
| EA | ZBH | |
|---|---|---|
Market Cap | $51.97B | $17.44B |
Sector | Technology | Health |
52-Week High | $207.27 | $107.71 |
52-Week Low | $147.79 | $79.58 |
Enterprise Value | $50.54B | $24.49B |
Dividend Yield | 0.37% | 1.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Electronic Arts (EA) trades at $206.65, showing modest daily gains of 0.15%. The stock exhibits a bullish technical structure with moving averages aligned positively, though oscillators signal caution with RSI levels above 70. Fundamentally, EA maintains strong profitability with 78.97% gross margins and 11.78% net income margins, but valuation metrics appear elevated with a P/E of 59.05 and P/S of 6.96. Recent business developments include the successful launch of EA SPORTS College Football 27 and the introduction of EA Advertising platform for in-game brand integration.
The outlook balances strong franchise execution against valuation concerns. Investment opportunities stem from EA's dominant gaming portfolio, recurring revenue streams, and new advertising monetization. Key risks include recent earnings misses, potential regulatory scrutiny of the rumored $55 billion Saudi acquisition (Reuters, June 24, 2026), and stretched valuation multiples that may limit near-term upside despite analyst consensus leaning positive.
Zimmer Biomet (ZBH) trades at $91.03, down 3.24% on the day, with a bullish technical signal from moving averages and neutral oscillators. The stock shows consistent earnings beats in recent quarters, with Q2 2026 results pending. Revenue growth has climbed from $6.9B in 2022 to $8.2B in 2025, though net income margin dipped to 8.56%. Recent corporate developments include a $140M acquisition and expansion in India, supporting long-term growth initiatives.
The outlook remains cautiously optimistic with a consensus price target of $97.67, implying 7% upside. Key opportunities include operational efficiency and market share gains, while risks involve debt levels rising to 32.57% of assets and competitive pressures in medical technology. Earnings on August 5 will be critical for near-term direction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Electronic Arts Inc.
EA is one of the world's largest third-party video game publishers and has transitioned from a console-based video game publisher to the one of the largest publishers on consoles, PC, and mobile. The firm owns number of large franchises, including Madden, FIFA, Battlefield, Apex Legends, Mass Effect, Dragon's Age, and Need for Speed.
Read more on EA →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
